In this position, Mr Titus will use his significant biotechnology industry experience to lead finance activities and investor relations for the company as well as oversee human resources, and legal affairs.
Mr Titus served most recently as senior vice president of finance and CFO at Kosan Biosciences. Prior to that, Mr Titus was CFO and vice president at Nuvelo. Mr Titus earned a bachelor of science degree in accounting from University of South Florida and a bachelor of science degree in finance from University of Florida.
Friedhelm Blobel, president and CEO of SciClone, said: “With an impressive track record that spans more than 20 years in the biotechnology and healthcare sectors, Gary brings extensive expertise to SciClone. His broad experience in finance and corporate development as well as relationships within the investment community will be highly valuable to SciClone as we continue to focus on growing our global operating business and continue developing our pipeline of product candidates in oncology and viral infectious diseases.”